Pfizer begins application for Canada's approval of Covid-19 pill

The country has identified seven people with the new variant as of Nov. 30.

Pfizer to acquire oncology specialist Medivation for $ 14 bn
Premium

Reuters
Pfizer Inc said on Wednesday it had started the real-time submission of its application seeking Health Canada's approval of its oral COVID-19 antiviral drug candidate.

The pill, PF-07321332, is designed to block a key enzyme needed for the coronavirus to multiply.

The move comes after the Canadian government announced on Tuesday that it was in advanced talks with Pfizer and Merck & Co Inc regarding a purchase agreement for their COVID-19 antiviral drugs, as the country attempts to control the spread of the Omicron coronavirus variant.

The country has identified seven people with the new variant as of Nov. 30.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Dec 02 2021 | 2:13 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com